Professor Commentary Module II (Part 2)
Upcoming SlideShare
Loading in...5
×
 

Professor Commentary Module II (Part 2)

on

  • 642 views

Part 2 of the commentary for Module 6, Qualitative Research, is the PowerPoint for Chapter 16 of the text.

Part 2 of the commentary for Module 6, Qualitative Research, is the PowerPoint for Chapter 16 of the text.

Statistics

Views

Total Views
642
Views on SlideShare
642
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Professor Commentary Module II (Part 2) Professor Commentary Module II (Part 2) Presentation Transcript

  • Chapter 6 Drug Therapy in the 21st Century
  • Changes in Health Care in the 21 st Century
    • Access to medical and pharmacologic information is available from many sources
    • Consumers are taking steps to demand specific treatments and considerations
    • Alternative therapies are being offered and advertised
    • Financial pressures are leading to early discharge
    • Patient teaching and home care provisions are vital
  • Federal Guidelines—Drug Advertising
    • When the advertisement states the indication, it must also include:
      • Contraindications
      • Adverse effects
      • Precautions
  • Internet Sources for Drug Information
    • Pharmaceutical company information sites
    • Chat rooms with other people who are taking the drug
    • Online pharmacies
    • Lists of government regulations
    • Research reports about the drug and its effectiveness
  • Internet Site Evaluation
    • Navigation
      • Is the site easy to access and navigate or confusing?
    • Contributor
      • Who prepared the site and what are his qualifications? Is it reviewed, or is it purely commercial?
    • Dates
      • Is the site updated frequently?
    • Accuracy/reliability
      • Is the information supported by other sites, accurate, and in agreement with other sources you have reviewed? Are other links listed?
  • Problems Associated With OTC Medications
    • Can mask the signs and symptoms of disease
    • Can interact with prescription drugs
    • Can be taken in greater than the recommended dose, leading to toxicity
  • Over-the-Counter Drugs
    • Drugs that were “grandfathered” in
    • Former prescription drugs that have been tested and found to be safe for the general public if used as directed
  • Alternative Therapy Drawbacks
    • The active ingredient has not been tested by the FDA
    • Incidental ingredients are unknown
    • Patients do not always mention these therapies to their health care providers
    • Drug–alternative therapy interactions may occur
  • Controls for Alternative Therapy
    • Herbal medications and alternative therapies are not controlled or tested by the FDA
    • Advertisement for these drugs is not restricted because they are considered dietary supplements
    • No regulation by any industry
  • Off-Label Medications
    • Definition
      • The use of a drug for an indication that is not approved by the FDA
    • Occurrence
      • Commonly takes place in groups of patients for whom there is little premarketing testing
      • Used with pediatric and geriatric populations
  • Health Care in Crisis
    • Skyrocketing cost of medical care and drugs
    • Huge research and equipment requirements to meet consumer demands
    • Rising cost of health insurance
    • Earlier discharge from hospitals
  • Measures to Protect the Public From Bioterrorism
    • Emergency preparedness at all levels of the government
  • Treatments for Exposure to Biological/Chemical Weapons
    • Insert table 6.3